A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries
Clinical trial NCT06887972 · COMPLETED
Trial details
- NCT number
- NCT06887972
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-21
- Primary completion
- 2025-10-24
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.